This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Magnachem International Laboratories, Inc.. Active years: 2012-2013.
Company Filing History:
Years Active: 2012-2013
Title: Innovations by Federico M Gomez
Introduction
Federico M Gomez is a notable inventor based in Boca Raton, FL (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, his work focuses on developing compounds that alleviate pain and target cancer cells.
Latest Patents
One of his latest patents is titled "Synthetic lactone formulations and method of use." This invention involves natural and synthetic compounds with a lactone structure that are effective in alleviating pain associated with various cancers, including melanoma, leukemia, and breast cancer. Initial studies indicate that patients can be taken off morphine when administered the preferred alpha-methylene-gamma-butyrolactone in a dosage of 60 to 120 mg/day intramuscularly. Another significant patent is the "Method for screening for compounds selectively interacting with RAD9." This patent highlights the effectiveness of Securolide, a compound that targets the hRad9 gene and is cytoselective for mutants of hRad9. Studies have shown that Securolide can produce DNA lesions in cancer cells, leading to apoptosis and providing a potential treatment for several types of cancer.
Career Highlights
Federico M Gomez works at Magnachem International Laboratories, Inc., where he continues to innovate in the field of cancer research. His work has the potential to change the landscape of cancer treatment and pain management.
Collaborations
He collaborates with notable colleagues, including C Federico Gomez Garcia-Godoy and David Terrero, to further advance his research and innovations.
Conclusion
Federico M Gomez is a pioneering inventor whose work in synthetic lactone formulations and cancer treatment showcases his commitment to improving patient outcomes. His contributions are vital in the ongoing fight against cancer and pain management.